Teva Wins Appeal Over Merck's Fosamax Patent
In an unexpected decision that could prove economically damaging for U.S. drug maker Merck, the U.S. Court of Appeals for the Federal Circuit has found that one of the patents for...To view the full article, register now.
Already a subscriber? Click here to view full article